Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002104761 | SCV002389228 | likely benign | not provided | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002104761 | SCV003195137 | uncertain significance | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004612135 | SCV005108804 | uncertain significance | Inborn genetic diseases | 2024-03-19 | criteria provided, single submitter | clinical testing | The c.3967C>A (p.P1323T) alteration is located in exon 52 (coding exon 52) of the COL11A1 gene. This alteration results from a C to A substitution at nucleotide position 3967, causing the proline (P) at amino acid position 1323 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |